{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T12:03:33Z","timestamp":1793793813408,"version":"4.6.1"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T00:00:00Z","timestamp":1733788800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T00:00:00Z","timestamp":1733788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["HL162564-02, R61AI161805"],"award-info":[{"award-number":["HL162564-02, R61AI161805"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["HL162564-02"],"award-info":[{"award-number":["HL162564-02"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["HL162564-02"],"award-info":[{"award-number":["HL162564-02"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["HL152960, DK054759, 75N92019C00010"],"award-info":[{"award-number":["HL152960, DK054759, 75N92019C00010"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["HL152960, DK054759, 75N92019C00010"],"award-info":[{"award-number":["HL152960, DK054759, 75N92019C00010"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["HL152960, DK054759, 75N92019C00010"],"award-info":[{"award-number":["HL152960, DK054759, 75N92019C00010"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["HL152960, DK054759, 75N92019C00010"],"award-info":[{"award-number":["HL152960, DK054759, 75N92019C00010"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["HL152960, DK054759, 75N92019C00010"],"award-info":[{"award-number":["HL152960, DK054759, 75N92019C00010"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001448","name":"Alpha-1 Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001448","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["5P30-CA14051"],"award-info":[{"award-number":["5P30-CA14051"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","award":["N\/a"],"award-info":[{"award-number":["N\/a"]}],"id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}],"id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}],"id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["WITTEN19XX0, 004831F5222"],"award-info":[{"award-number":["WITTEN19XX0, 004831F5222"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Biotechnol"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1038\/s41587-024-02490-y","type":"journal-article","created":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T05:46:35Z","timestamp":1733809595000},"page":"1790-1799","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":159,"title":["Artificial intelligence-guided design of lipid nanoparticles for pulmonary gene therapy"],"prefix":"10.1038","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0037-5999","authenticated-orcid":false,"given":"Jacob","family":"Witten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5697-6422","authenticated-orcid":false,"given":"Idris","family":"Raji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7081-0138","authenticated-orcid":false,"given":"Rajith S.","family":"Manan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Beyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Bartlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghua","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5832-3425","authenticated-orcid":false,"given":"Mehrnoosh","family":"Ebadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junying","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9229-4154","authenticated-orcid":false,"given":"Dien","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Favour","family":"Oladimeji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9826-5976","authenticated-orcid":false,"given":"Allen Yujie","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6132-1391","authenticated-orcid":false,"given":"Elise","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haseeb","family":"Mughal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ava","family":"Self","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0774-6975","authenticated-orcid":false,"given":"Evan","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8210-5567","authenticated-orcid":false,"given":"Ziying","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2389-9277","authenticated-orcid":false,"given":"John F.","family":"Engelhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4255-0492","authenticated-orcid":false,"given":"Robert","family":"Langer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5629-4798","authenticated-orcid":false,"given":"Daniel G.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,10]]},"reference":[{"key":"2490_CR1","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","volume":"6","author":"X Hou","year":"2021","unstructured":"Hou, X., Zaks, T., Langer, R. & Dong, Y. Lipid nanoparticles for mRNA delivery. Nat. Rev. Mater. 6, 1078\u20131094 (2021).","journal-title":"Nat. Rev. Mater."},{"key":"2490_CR2","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/s41587-022-01294-2","volume":"40","author":"AJ Barbier","year":"2022","unstructured":"Barbier, A. J., Jiang, A. Y., Zhang, P., Wooster, R. & Anderson, D. G. The clinical progress of mRNA vaccines and immunotherapies. Nat. Biotechnol. 40, 840\u2013854 (2022).","journal-title":"Nat. Biotechnol."},{"key":"2490_CR3","doi-asserted-by":"publisher","first-page":"e2307798120","DOI":"10.1073\/pnas.2307798120","volume":"121","author":"J Witten","year":"2024","unstructured":"Witten, J., Hu, Y., Langer, R. & Anderson, D. G. Recent advances in nanoparticulate RNA delivery systems. Proc. Natl Acad. Sci. USA 121, e2307798120 (2024).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2490_CR4","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack, F. P. et al. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. N. Engl. J. Med. 383, 2603\u20132615 (2020).","journal-title":"N. Engl. J. Med."},{"key":"2490_CR5","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","volume":"384","author":"LR Baden","year":"2021","unstructured":"Baden, L. R. et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N. Engl. J. Med. 384, 403\u2013416 (2021).","journal-title":"N. Engl. J. Med."},{"key":"2490_CR6","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1056\/NEJMoa2107454","volume":"385","author":"JD Gillmore","year":"2021","unstructured":"Gillmore, J. D. et al. CRISPR\u2013Cas9 in vivo gene editing for transthyretin amyloidosis. N. Engl. J. Med. 385, 493\u2013502 (2021).","journal-title":"N. Engl. J. Med."},{"key":"2490_CR7","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/s41587-021-00933-4","volume":"39","author":"T Rothgangl","year":"2021","unstructured":"Rothgangl, T. et al. In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels. Nat. Biotechnol. 39, 949\u2013957 (2021).","journal-title":"Nat. Biotechnol."},{"key":"2490_CR8","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41569-021-00662-w","volume":"19","author":"S Heymans","year":"2022","unstructured":"Heymans, S. & Cooper, L. T. Myocarditis after COVID-19 mRNA vaccination: clinical observations and potential mechanisms. Nat. Rev. Cardiol. 19, 75\u201377 (2022).","journal-title":"Nat. Rev. Cardiol."},{"key":"2490_CR9","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/s41587-023-01774-z","volume":"42","author":"A vander Straeten","year":"2024","unstructured":"vander Straeten, A. et al. A microneedle vaccine printer for thermostable COVID-19 mRNA vaccines. Nat. Biotechnol. 42, 510\u2013517 (2024).","journal-title":"Nat. Biotechnol."},{"key":"2490_CR10","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1016\/j.ymthe.2022.02.001","volume":"30","author":"H Muramatsu","year":"2022","unstructured":"Muramatsu, H. et al. Lyophilization provides long-term stability for a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine. Mol. Ther. 30, 1941\u20131951 (2022).","journal-title":"Mol. Ther."},{"key":"2490_CR11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1021\/acs.accounts.1c00601","volume":"55","author":"D Loughrey","year":"2022","unstructured":"Loughrey, D. & Dahlman, J. E. Non-liver mRNA delivery. Acc. Chem. Res. 55, 13\u201323 (2022).","journal-title":"Acc. Chem. Res."},{"key":"2490_CR12","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.gendis.2018.11.005","volume":"6","author":"CA Hodges","year":"2018","unstructured":"Hodges, C. A. & Conlon, R. A. Delivering on the promise of gene editing for cystic fibrosis. Genes Dis. 6, 97\u2013108 (2018).","journal-title":"Genes Dis."},{"key":"2490_CR13","doi-asserted-by":"publisher","first-page":"662110","DOI":"10.3389\/fphar.2021.662110","volume":"12","author":"M Ensinck","year":"2021","unstructured":"Ensinck, M., Mottais, A., Detry, C., Leal, T. & Carlon, M. S. On the corner of models and cure: gene editing in cystic fibrosis. Front. Pharmacol. 12, 662110 (2021).","journal-title":"Front. Pharmacol."},{"key":"2490_CR14","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.ymthe.2021.01.010","volume":"29","author":"SH Choi","year":"2021","unstructured":"Choi, S. H. & Engelhardt, J. F. Gene therapy for cystic fibrosis: lessons learned and paths forward. Mol. Ther. 29, 428\u2013430 (2021).","journal-title":"Mol. Ther."},{"key":"2490_CR15","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1038\/s41587-019-0247-3","volume":"37","author":"L Miao","year":"2019","unstructured":"Miao, L. et al. Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation. Nat. Biotechnol. 37, 1174\u20131185 (2019).","journal-title":"Nat. Biotechnol."},{"key":"2490_CR16","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.omtm.2021.01.003","volume":"20","author":"MJR Ruigrok","year":"2021","unstructured":"Ruigrok, M. J. R., Frijlink, H. W., Melgert, B. N., Olinga, P. & Hinrichs, W. L. J. Gene therapy strategies for idiopathic pulmonary fibrosis: recent advances, current challenges, and future directions. Mol. Ther. Methods Clin. Dev. 20, 483\u2013496 (2021).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"2490_CR17","doi-asserted-by":"publisher","first-page":"eabn7162","DOI":"10.1126\/sciadv.abn7162","volume":"8","author":"X Bai","year":"2022","unstructured":"Bai, X. et al. Inhaled siRNA nanoparticles targeting IL11 inhibit lung fibrosis and improve pulmonary function post-bleomycin challenge. Sci. Adv. 8, eabn7162 (2022).","journal-title":"Sci. Adv."},{"key":"2490_CR18","doi-asserted-by":"publisher","first-page":"e2107506","DOI":"10.1002\/adma.202107506","volume":"34","author":"R Zhang","year":"2022","unstructured":"Zhang, R. et al. Inhaled mRNA nanoformulation with biogenic ribosomal protein reverses established pulmonary fibrosis in a bleomycin-induced murine model. Adv. Mater. 34, e2107506 (2022).","journal-title":"Adv. Mater."},{"key":"2490_CR19","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.3390\/pharmaceutics13081281","volume":"13","author":"S Guan","year":"2021","unstructured":"Guan, S., Darmst\u00e4dter, M., Xu, C. & Rosenecker, J. In vitro investigations on optimizing and nebulization of IVT-mRNA formulations for potential pulmonary-based alpha-1-antitrypsin deficiency treatment. Pharmaceutics 13, 1281 (2021).","journal-title":"Pharmaceutics"},{"key":"2490_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2017.08.007","volume":"182","author":"D-D Wu","year":"2018","unstructured":"Wu, D.-D. et al. The potential for targeted rewriting of epigenetic marks in COPD as a new therapeutic approach. Pharmacol. Ther. 182, 1\u201314 (2018).","journal-title":"Pharmacol. Ther."},{"key":"2490_CR21","doi-asserted-by":"publisher","first-page":"102134","DOI":"10.1016\/j.pupt.2022.102134","volume":"75","author":"CJ Woo","year":"2022","unstructured":"Woo, C. J. et al. Inhaled delivery of a lipid nanoparticle encapsulated messenger RNA encoding a ciliary protein for the treatment of primary ciliary dyskinesia. Pulm. Pharmacol. Ther. 75, 102134 (2022).","journal-title":"Pulm. Pharmacol. Ther."},{"key":"2490_CR22","doi-asserted-by":"publisher","first-page":"eaay7973","DOI":"10.1126\/sciadv.aay7973","volume":"6","author":"AL da Silva","year":"2020","unstructured":"da Silva, A. L. et al. Nanoparticle-based thymulin gene therapy therapeutically reverses key pathology of experimental allergic asthma. Sci. Adv. 6, eaay7973 (2020).","journal-title":"Sci. Adv."},{"key":"2490_CR23","doi-asserted-by":"publisher","first-page":"e0154001","DOI":"10.1371\/journal.pone.0154001","volume":"11","author":"F Zeyer","year":"2016","unstructured":"Zeyer, F. et al. mRNA-mediated gene supplementation of Toll-like receptors as treatment strategy for asthma in vivo. PLoS ONE 11, e0154001 (2016).","journal-title":"PLoS ONE"},{"key":"2490_CR24","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/j.ymthe.2018.03.010","volume":"26","author":"S Sabnis","year":"2018","unstructured":"Sabnis, S. et al. A novel amino lipid series for mRNA delivery: improved endosomal escape and sustained pharmacology and safety in non-human primates. Mol. Ther. 26, 1509\u20131519 (2018).","journal-title":"Mol. Ther."},{"key":"2490_CR25","doi-asserted-by":"publisher","first-page":"2370001","DOI":"10.1002\/smsc.202370001","volume":"3","author":"K Hashiba","year":"2023","unstructured":"Hashiba, K. et al. Branching ionizable lipids can enhance the stability, fusogenicity, and functional delivery of mRNA. Small Sci. 3, 2370001 (2023).","journal-title":"Small Sci."},{"key":"2490_CR26","doi-asserted-by":"publisher","first-page":"2209624","DOI":"10.1002\/adma.202209624","volume":"35","author":"K Lam","year":"2023","unstructured":"Lam, K. et al. Unsaturated, trialkyl ionizable lipids are versatile LNP components for therapeutic and vaccine applications. Adv. Mater. 35, 2209624 (2023).","journal-title":"Adv. Mater."},{"key":"2490_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5277","volume":"5","author":"KA Whitehead","year":"2014","unstructured":"Whitehead, K. A. et al. Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity. Nat. Commun. 5, 4277 (2014).","journal-title":"Nat. Commun."},{"key":"2490_CR28","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1038\/s41563-024-01867-3","volume":"23","author":"B Li","year":"2024","unstructured":"Li, B. et al. Accelerating ionizable lipid discovery for mRNA delivery using machine learning and combinatorial chemistry. Nat. Mater. 23, 1002\u20131008 (2024).","journal-title":"Nat. Mater."},{"key":"2490_CR29","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.cell.2020.01.021","volume":"180","author":"JM Stokes","year":"2020","unstructured":"Stokes, J. M. et al. A deep learning approach to antibiotic discovery. Cell 180, 688\u2013702.e13 (2020).","journal-title":"Cell"},{"key":"2490_CR30","doi-asserted-by":"publisher","first-page":"3370","DOI":"10.1021\/acs.jcim.9b00237","volume":"59","author":"K Yang","year":"2019","unstructured":"Yang, K. et al. Analyzing learned molecular representations for property prediction. J. Chem. Inf. Model. 59, 3370\u20133388 (2019).","journal-title":"J. Chem. Inf. Model."},{"key":"2490_CR31","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1021\/acscentsci.1c00546","volume":"7","author":"AP Soleimany","year":"2021","unstructured":"Soleimany, A. P. et al. Evidential deep learning for guided molecular property prediction and discovery. ACS Cent. Sci. 7, 1356\u20131367 (2021).","journal-title":"ACS Cent. Sci."},{"key":"2490_CR32","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/s41565-021-00870-y","volume":"16","author":"D Reker","year":"2021","unstructured":"Reker, D. et al. Computationally guided high-throughput design of self-assembling drug nanoparticles. Nat. Nanotechnol. 16, 725\u2013733 (2021).","journal-title":"Nat. Nanotechnol."},{"key":"2490_CR33","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1038\/s41589-023-01349-8","volume":"19","author":"G Liu","year":"2023","unstructured":"Liu, G. et al. Deep learning-guided discovery of an antibiotic targeting Acinetobacter baumannii. Nat. Chem. Biol. 19, 1342\u20131350 (2023).","journal-title":"Nat. Chem. Biol."},{"key":"2490_CR34","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41586-023-06887-8","volume":"626","author":"F Wong","year":"2024","unstructured":"Wong, F. et al. Discovery of a structural class of antibiotics with explainable deep learning. Nature 626, 177\u2013185 (2024).","journal-title":"Nature"},{"key":"2490_CR35","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1038\/s41551-023-01030-4","volume":"7","author":"LH Rhym","year":"2023","unstructured":"Rhym, L. H., Manan, R. S., Koller, A., Stephanie, G. & Anderson, D. G. Peptide-encoding mRNA barcodes for the high-throughput in vivo screening of libraries of lipid nanoparticles for mRNA delivery. Nat. Biomed. Eng. 7, 901\u2013910 (2023).","journal-title":"Nat. Biomed. Eng."},{"key":"2490_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20439-y","volume":"12","author":"KA Ryan","year":"2021","unstructured":"Ryan, K. A. et al. Dose-dependent response to infection with SARS-CoV-2 in the ferret model and evidence of protective immunity. Nat. Commun. 12, 81 (2021).","journal-title":"Nat. Commun."},{"key":"2490_CR37","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1016\/j.jcf.2017.09.001","volume":"17","author":"BH Rosen","year":"2018","unstructured":"Rosen, B. H. et al. Animal and model systems for studying cystic fibrosis. J. Cyst. Fibros. 17, S28\u2013S34 (2018).","journal-title":"J. Cyst. Fibros."},{"key":"2490_CR38","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/s41586-023-06549-9","volume":"621","author":"F Yuan","year":"2023","unstructured":"Yuan, F. et al. Transgenic ferret models define pulmonary ionocyte diversity and function. Nature 621, 857\u2013867 (2023).","journal-title":"Nature"},{"key":"2490_CR39","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/s41563-022-01404-0","volume":"22","author":"L Rotolo","year":"2023","unstructured":"Rotolo, L. et al. Species-agnostic polymeric formulations for inhalable messenger RNA delivery to the lung. Nat. Mater. 22, 369\u2013379 (2023).","journal-title":"Nat. Mater."},{"key":"2490_CR40","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1056\/NEJMra1813799","volume":"380","author":"RC Boucher","year":"2019","unstructured":"Boucher, R. C. Muco-obstructive lung diseases. N. Engl. J. Med. 380, 1941\u20131953 (2019).","journal-title":"N. Engl. J. Med."},{"key":"2490_CR41","doi-asserted-by":"publisher","unstructured":"Li, B. et al. Enhancing the immunogenicity of lipid-nanoparticle mRNA vaccines by adjuvanting the ionizable lipid and the mRNA. Nat. Biomed. Eng. https:\/\/doi.org\/10.1038\/s41551-023-01082-6 (2023).","DOI":"10.1038\/s41551-023-01082-6"},{"key":"2490_CR42","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/s41565-023-01548-3","volume":"19","author":"AY Jiang","year":"2024","unstructured":"Jiang, A. Y. et al. Combinatorial development of nebulized mRNA delivery formulations for the lungs. Nat. Nanotechnol. 19, 364\u2013375 (2024).","journal-title":"Nat. Nanotechnol."},{"key":"2490_CR43","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1002\/anie.201610209","volume":"56","author":"JB Miller","year":"2017","unstructured":"Miller, J. B. et al. Non-viral CRISPR\/Cas gene editing in vitro and in vivo enabled by synthetic nanoparticle co-delivery of Cas9 mRNA and sgRNA. Angew. Chem. Int. Ed. 56, 1059\u20131063 (2017).","journal-title":"Angew. Chem. Int. Ed."},{"key":"2490_CR44","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1073\/pnas.1520756113","volume":"113","author":"K Zhou","year":"2016","unstructured":"Zhou, K. et al. Modular degradable dendrimers enable small RNAs to extend survival in an aggressive liver cancer model. Proc. Natl Acad. Sci. USA 113, 520\u2013525 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2490_CR45","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41563-020-00886-0","volume":"20","author":"S Liu","year":"2021","unstructured":"Liu, S. et al. Membrane-destabilizing ionizable phospholipids for organ-selective mRNA delivery and CRISPR\u2013Cas gene editing. Nat. Mater. 20, 701\u2013710 (2021).","journal-title":"Nat. Mater."},{"key":"2490_CR46","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1038\/s41587-023-01679-x","volume":"41","author":"B Li","year":"2023","unstructured":"Li, B. et al. Combinatorial design of nanoparticles for pulmonary mRNA delivery and genome editing. Nat. Biotechnol. 41, 1410\u20131415 (2023).","journal-title":"Nat. Biotechnol."},{"key":"2490_CR47","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nbt1402","volume":"26","author":"A Akinc","year":"2008","unstructured":"Akinc, A. et al. A combinatorial library of lipid-like materials for delivery of RNAi therapeutics. Nat. Biotechnol. 26, 561\u2013569 (2008).","journal-title":"Nat. Biotechnol."},{"key":"2490_CR48","doi-asserted-by":"publisher","first-page":"5912","DOI":"10.1002\/ange.202013927","volume":"133","author":"SM Lee","year":"2021","unstructured":"Lee, S. M. et al. A systematic study of unsaturation in lipid nanoparticles leads to improved mRNA transfection in vivo. Angew. Chem. 133, 5912\u20135917 (2021).","journal-title":"Angew. Chem."},{"key":"2490_CR49","doi-asserted-by":"publisher","first-page":"8160","DOI":"10.1016\/j.biomaterials.2012.07.044","volume":"33","author":"L Li","year":"2012","unstructured":"Li, L. et al. A biomimetic lipid library for gene delivery through thiol-yne click chemistry. Biomaterials 33, 8160\u20138166 (2012).","journal-title":"Biomaterials"},{"key":"2490_CR50","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1021\/acs.jcim.3c01250","volume":"64","author":"E Heid","year":"2024","unstructured":"Heid, E. et al. Chemprop: a machine learning package for chemical property prediction. J. Chem. Inf. Model. 64, 9\u201317 (2024).","journal-title":"J. Chem. Inf. Model."},{"key":"2490_CR51","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1039\/C7SC02664A","volume":"9","author":"Z Wu","year":"2018","unstructured":"Wu, Z. et al. MoleculeNet: a benchmark for molecular machine learning. Chem. Sci. 9, 513\u2013530 (2018).","journal-title":"Chem. Sci."},{"key":"2490_CR52","doi-asserted-by":"publisher","first-page":"e202310401","DOI":"10.1002\/anie.202310401","volume":"62","author":"Z He","year":"2023","unstructured":"He, Z. et al. A multidimensional approach to modulating ionizable lipids for high-performing and organ-selective mRNA delivery. Angew. Chem. Int. Ed. 62, e202310401 (2023).","journal-title":"Angew. Chem. Int. Ed."},{"key":"2490_CR53","doi-asserted-by":"publisher","first-page":"7300","DOI":"10.1021\/acs.nanolett.5b02497","volume":"15","author":"KJ Kauffman","year":"2015","unstructured":"Kauffman, K. J. et al. Optimization of lipid nanoparticle formulations for mRNA delivery in vivo with fractional factorial and definitive screening designs. Nano Lett. 15, 7300\u20137306 (2015).","journal-title":"Nano Lett."},{"key":"2490_CR54","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/nbt.2612","volume":"31","author":"J Gilleron","year":"2013","unstructured":"Gilleron, J. et al. Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escape. Nat. Biotechnol. 31, 638\u2013646 (2013).","journal-title":"Nat. Biotechnol."},{"key":"2490_CR55","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1038\/s42003-021-02441-2","volume":"4","author":"MJ Carrasco","year":"2021","unstructured":"Carrasco, M. J. et al. Ionization and structural properties of mRNA lipid nanoparticles influence expression in intramuscular and intravascular administration. Commun. Biol. 4, 956 (2021).","journal-title":"Commun. Biol."},{"key":"2490_CR56","doi-asserted-by":"publisher","first-page":"e124863","DOI":"10.1172\/jci.insight.124863","volume":"4","author":"AJ Fischer","year":"2019","unstructured":"Fischer, A. J. et al. Mucus strands from submucosal glands initiate mucociliary transport of large particles. JCI Insight 4, e124863 (2019).","journal-title":"JCI Insight"},{"key":"2490_CR57","doi-asserted-by":"publisher","first-page":"e59653","DOI":"10.7554\/eLife.59653","volume":"9","author":"LS Ostedgaard","year":"2020","unstructured":"Ostedgaard, L. S. et al. Lack of airway submucosal glands impairs respiratory host defenses. eLife 9, e59653 (2020).","journal-title":"eLife"},{"key":"2490_CR58","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1242\/dev.143784","volume":"144","author":"PR Tata","year":"2017","unstructured":"Tata, P. R. & Rajagopal, J. Plasticity in the lung: making and breaking cell identity. Development 144, 755\u2013766 (2017).","journal-title":"Development"},{"key":"2490_CR59","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41586-018-0394-6","volume":"560","author":"LW Plasschaert","year":"2018","unstructured":"Plasschaert, L. W. et al. A single-cell atlas of the airway epithelium reveals the CFTR-rich pulmonary ionocyte. Nature 560, 377\u2013381 (2018).","journal-title":"Nature"},{"key":"2490_CR60","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1146\/annurev-pathol-042420-094031","volume":"17","author":"VS Shah","year":"2022","unstructured":"Shah, V. S., Chivukula, R. R., Lin, B., Waghray, A. & Rajagopal, J. Cystic fibrosis and the cells of the airway epithelium: what are ionocytes and what do they do? Annu. Rev. Pathol. Mech. Dis. 17, 23\u201346 (2022).","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"2490_CR61","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13321-015-0069-3","volume":"7","author":"D Bajusz","year":"2015","unstructured":"Bajusz, D., R\u00e1cz, A. & H\u00e9berger, K. Why is Tanimoto index an appropriate choice for fingerprint-based similarity calculations? J. Cheminform. 7, 20 (2015).","journal-title":"J. Cheminform."},{"key":"2490_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16248-y","volume":"11","author":"L Miao","year":"2020","unstructured":"Miao, L. et al. Synergistic lipid compositions for albumin receptor mediated delivery of mRNA to the liver. Nat. Commun. 11, 2424 (2020).","journal-title":"Nat. Commun."},{"key":"2490_CR63","unstructured":"Witten, J. & Collins, E. LNP ML. GitHub https:\/\/github.com\/jswitten\/LNP_ML (2024)."},{"key":"2490_CR64","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/s44222-023-00114-9","volume":"2","author":"Z Guo","year":"2024","unstructured":"Guo, Z. et al. Diffusion models in bioinformatics and computational biology. Nat. Rev. Bioeng. 2, 136\u2013154 (2024).","journal-title":"Nat. Rev. Bioeng."},{"key":"2490_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-18751-2","volume":"12","author":"C Reverberi","year":"2022","unstructured":"Reverberi, C. et al. Experimental evidence of effective human\u2013AI collaboration in medical decision-making. Sci. Rep. 12, 14952 (2022).","journal-title":"Sci. Rep."},{"key":"2490_CR66","doi-asserted-by":"publisher","first-page":"6527","DOI":"10.1039\/D3TB00649B","volume":"11","author":"Y Xu","year":"2023","unstructured":"Xu, Y., Golubovic, A., Xu, S., Pan, A. & Li, B. Rational design and combinatorial chemistry of ionizable lipids for RNA delivery. J. Mater. Chem. B 11, 6527\u20136539 (2023).","journal-title":"J. Mater. Chem. B"},{"key":"2490_CR67","doi-asserted-by":"publisher","first-page":"2300188","DOI":"10.1002\/advs.202300188","volume":"10","author":"S Du","year":"2023","unstructured":"Du, S. et al. Cholesterol-amino-phosphate (CAP) derived lipid nanoparticles for delivery of self-amplifying RNA and restoration of spermatogenesis in infertile mice. Adv. Sci. 10, 2300188 (2023).","journal-title":"Adv. Sci."},{"key":"2490_CR68","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1021\/mp200604h","volume":"9","author":"O Andries","year":"2012","unstructured":"Andries, O. et al. Comparison of the gene transfer efficiency of mRNA\/GL67 and pDNA\/GL67 complexes in respiratory cells. Mol. Pharm. 9, 2136\u20132145 (2012).","journal-title":"Mol. Pharm."},{"key":"2490_CR69","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41565-019-0600-1","volume":"15","author":"X Hou","year":"2020","unstructured":"Hou, X. et al. Vitamin lipid nanoparticles enable adoptive macrophage transfer for the treatment of multidrug-resistant bacterial sepsis. Nat. Nanotechnol. 15, 41\u201346 (2020).","journal-title":"Nat. Nanotechnol."},{"key":"2490_CR70","doi-asserted-by":"publisher","first-page":"18758","DOI":"10.1021\/acsnano.3c02251","volume":"17","author":"R Oyama","year":"2023","unstructured":"Oyama, R. et al. An ionizable lipid material with a vitamin E scaffold as an mRNA vaccine platform for efficient cytotoxic T cell responses. ACS Nano 17, 18758\u201318774 (2023).","journal-title":"ACS Nano"},{"key":"2490_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2023.122243","volume":"301","author":"RL Goldman","year":"2023","unstructured":"Goldman, R. L. et al. Understanding structure activity relationships of good HEPES lipids for lipid nanoparticle mRNA vaccine applications. Biomaterials 301, 122243 (2023).","journal-title":"Biomaterials"},{"key":"2490_CR72","doi-asserted-by":"publisher","first-page":"R88","DOI":"10.1093\/hmg\/ddz139","volume":"28","author":"Z Yan","year":"2019","unstructured":"Yan, Z., McCray, P. B. Jr & Engelhardt, J. F. Advances in gene therapy for cystic fibrosis lung disease. Hum. Mol. Genet. 28, R88\u2013R94 (2019).","journal-title":"Hum. Mol. Genet."},{"key":"2490_CR73","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-021-03099-4","volume":"19","author":"J-A Lee","year":"2021","unstructured":"Lee, J.-A. et al. Gene therapy for cystic fibrosis: new tools for precision medicine. J. Transl. Med. 19, 452 (2021).","journal-title":"J. Transl. Med."},{"key":"2490_CR74","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1172\/JCI6330","volume":"103","author":"RC Boucher","year":"1999","unstructured":"Boucher, R. C. Status of gene therapy for cystic fibrosis lung disease. J. Clin. Invest. 103, 441\u2013445 (1999).","journal-title":"J. Clin. Invest."},{"key":"2490_CR75","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jcf.2010.03.001","volume":"9","author":"M Ulrich","year":"2010","unstructured":"Ulrich, M. et al. Alveolar inflammation in cystic fibrosis. J. Cyst. Fibros. 9, 217\u2013227 (2010).","journal-title":"J. Cyst. Fibros."},{"key":"2490_CR76","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.3390\/cells11132055","volume":"11","author":"C-R Lin","year":"2022","unstructured":"Lin, C.-R., Bahmed, K. & Kosmider, B. Impaired alveolar re-epithelialization in pulmonary emphysema. Cells 11, 2055 (2022).","journal-title":"Cells"},{"key":"2490_CR77","doi-asserted-by":"publisher","first-page":"6948","DOI":"10.1021\/ja301621z","volume":"134","author":"D Chen","year":"2012","unstructured":"Chen, D. et al. Rapid discovery of potent siRNA-containing lipid nanoparticles enabled by controlled microfluidic formulation. J. Am. Chem. Soc. 134, 6948\u20136951 (2012).","journal-title":"J. Am. Chem. Soc."},{"key":"2490_CR78","doi-asserted-by":"publisher","first-page":"2200106","DOI":"10.1002\/anbr.202200106","volume":"3","author":"LT Ferguson","year":"2023","unstructured":"Ferguson, L. T. et al. Mechanisms by which liposomes improve inhaled drug delivery for alveolar diseases. Adv. NanoBiomed Res. 3, 2200106 (2023).","journal-title":"Adv. NanoBiomed Res."},{"key":"2490_CR79","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1038\/s41598-018-37192-4","volume":"9","author":"M Yu","year":"2019","unstructured":"Yu, M. et al. Highly efficient transgenesis in ferrets using CRISPR\/Cas9-mediated homology-independent insertion at the ROSA26 locus. Sci. Rep. 9, 1971 (2019).","journal-title":"Sci. Rep."},{"key":"2490_CR80","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.omtm.2020.09.008","volume":"19","author":"Y Tang","year":"2020","unstructured":"Tang, Y. et al. Repeat dosing of AAV2.5T to ferret lungs elicits an antibody response that diminishes transduction in an age-dependent manner. Mol. Ther. Methods Clin. Dev. 19, 186\u2013200 (2020).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"2490_CR81","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.omtm.2023.02.015","volume":"29","author":"Y Tang","year":"2023","unstructured":"Tang, Y. et al. Immunosuppression reduces rAAV2.5T neutralizing antibodies that limit efficacy following repeat dosing to ferret lungs. Mol. Ther. Methods Clin. Dev. 29, 70\u201380 (2023).","journal-title":"Mol. Ther. Methods Clin. Dev."}],"container-title":["Nature Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41587-024-02490-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41587-024-02490-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41587-024-02490-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T19:02:47Z","timestamp":1762974167000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41587-024-02490-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,10]]},"references-count":81,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["2490"],"URL":"https:\/\/doi.org\/10.1038\/s41587-024-02490-y","relation":{},"ISSN":["1087-0156","1546-1696"],"issn-type":[{"value":"1087-0156","type":"print"},{"value":"1546-1696","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,10]]},"assertion":[{"value":"18 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.W., I.R. and D.G.A. have filed a patent for the 4CR ketone biodegradable lipid library described herein and J.W., R.S.M. and D.G.A. have filed a patent for the branched-ester library described herein. Z.Y. and J.F.E. are consultants for Spirovant Sciences. D.G.A. receives research funding from Sanofi\/Translate Bio and is a Founder of oRNA Tx. R.L. is a co-founder and board of director of Moderna. He also serves on the board and has equity in Particles For Humanity. For a list of entities with which R.L. is, or has been recently involved compensated or uncompensated, see\n                      \n                      . The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}